STUDresearch · Peptide
Thymopentin
Also known as
TP-5 · RKDVY · thymopoietin pentapeptide
Community talk. May be wrong. Not medical advice. Not a protocol. Not for human or animal use.
Peptide
Niche talk
Systemic
Injection (route unspecified)
Immune / antimicrobial
Systemic immune-modulation research around a defined thymopoietin pentapeptide; plasma degradation is rapid ex vivo.
What people say
Thymopentin is TP-5, a defined RKDVY pentapeptide corresponding to thymopoietin residues 32–36. It is not a Khavinson bioregulator or another similarly named thymic product.
Doses people talk about
The inspected community thread did not report an amount used by the poster; the physician anecdote does not supply a self-use amount.
How it may feel
No firsthand felt sequence was available in the inspected discussion. The buyer asked for experiences, and the only outcome described was a second-hand physician story rather than the poster's result.
Legacy product-chart injection amount~50 mg per injection, daily or every other day
Preserved leaflet-style discussion places this within a roughly 5–10-day course; exact product and route context vary.
Half-life & effect duration
- Half-life in the body
- Human-plasma breakdown testAbout 30 seconds
- Felt duration people report
- Secondhand accountA year without UTIs after a 3-month course
- Direct firsthand durationNot consistently reported
Cycles people discuss
Preserved leaflet-style talk uses short 5–10-day courses, while the inspected thread relayed a physician's very different three-month course. Neither creates one validated calendar.
Timing
Preserved leaflet-style talk describes daily or every-other-day injections within 5–10-day courses. The inspected thread did not supply a firsthand amount, frequency or route.
Stacks
The preserved notes place TP-5 among multi-bioregulator discussions but do not establish a named or studied combination. The inspected thread did not provide a stack outcome.
Watch for
Unknowns: Long-term safety for gray-market preparations is often poorly characterized.
Tap a line to jump into the full notes. Research only — may be wrong.
Timing context & sources
Half-life in the body
No in-vivo human parent half-life was established; the well-known 30-second value is an ex-vivo plasma-degradation result.
A laboratory study reported rapid TP-5 degradation in human plasma with an in-vitro half-life of about 30 seconds.
Ex-vivo human plasma is not a dosed human concentration-time study; it cannot determine SubQ, IM or IV absorption and elimination.
- Thymopentin: stability considerations and potency by various routes of administration (opens in a new tab)PubMed abstract inspected: TP-5 is identified as Arg-Lys-Asp-Val-Tyr, corresponding to thymopoietin residues 32–36, and was rapidly degraded by proteolytic enzymes in human plasma with an in-vitro half-life of about 30 seconds.The reported clock is in-vitro stability in human plasma, not in-vivo pharmacokinetics in dosed people; it does not supply absorption, distribution or route-specific elimination.
Felt duration people report
No firsthand onset, offset or persistence account was present in the inspected discussion.
The poster had purchased thymopentin and asked for experiences; a claimed year without UTIs after a three-month course was attributed to the poster's physician, not to the poster.
Second-hand efficacy story with no product, amount, route, follow-up or independently observed outcome; it cannot support a felt-duration estimate.
- Seeking advice on dosing/efficacy of Thymopentin injections (opens in a new tab)Complete visible thread inspected. The poster said they had bought thymopentin in China on a physician's recommendation and asked for experiences; the only efficacy story was the poster's report that the physician used a three-month course and said it prevented UTIs for a year. No personal post-use outcome appeared.Sparse discussion with deleted comments and no first-person outcome from the purchaser; physician experience is second-hand and lacks amount, route and verification.
What people say
- immune (TP5) narrative: Community and regional literature frame benefits around immune (TP5) function and “normalization” language. forum
- What is thinner: Large modern multi-center RCTs are often absent for the specific peptide brand story. forum
- Why it trends: Thymopentin is discussed mainly for immune-related goals in community and secondary sources. forum
- What people claim: Anecdotes range from subtle to dramatic; lifestyle confounds are the rule. anecdote
- Time course: Early days are often side-effect or placebo window; multi-week blocks are the real checkpoint. forum
Doses people talk about
- Common product charts: often ~50 mg per injection on multi-day immune courses (product-dependent). forum
- Course length: frequently ~5–10 day short courses rather than indefinite daily use. forum
- Frequency: daily or every-other-day during the short course in leaflet-style talk. forum
- Honesty: exact mg depends on registered product form; research-chem labels vary. forum
- Framing: TP-5 immune peptide product culture in some countries. forum
How it may feel
- No firsthand outcome in the inspected thread: The purchaser asked for experiences before reporting use. A three-month UTI-prevention story concerned the poster's physician, not the poster, and no later personal result was visible. forum
- Courses: Often 10–20 day courses repeated a few times per year in bioregulator culture. forum
- Day 1: Most people notice logistics (route, sting, GI) more than a “miracle” effect from Thymopentin. forum
- Days 2–7: Side-effect window for many agents; benefits, if any, are easy to mis-attribute. forum
- Weeks 1–2: First honest checkpoint in self-logs. forum
Cycles people discuss
- Course culture: Short on, long off, repeat seasonally is the common pattern. forum
- Common pattern: Many self-protocols use weeks-on / weeks-off rather than indefinite daily use — cost and caution drive this more than hard science. forum
- No magic cycle: There is rarely one universal “correct” on/off calendar across forums. forum
- Reassess: Stop and reassess if adverse effects appear; this is not medical care. forum
Timing
- Timing practicalities: People time doses around side effects, training, and sleep more than perfect PK. forum
- Human-plasma stability, not patient PK: TP-5 was reported to degrade in vitro in human plasma with a half-life of about 30 seconds. That ex-vivo assay does not establish an in-vivo elimination half-life after SubQ, IM or IV administration. lab
- Published PK: Where human PK exists it should override forum half-life memes for Thymopentin. trial
More on what it is
- Evidence honesty: Much of the English-web discussion is secondary summaries and vendor literature; treat claims cautiously. forum
- Research posture: Educational summary of public discussion and literature themes only. forum
- How people talk about it: Forum volume is a popularity signal for Thymopentin, not proof it works for you. forum
- What it is: Thymopentin (TP-5; RKDVY) is a synthetic five-amino-acid fragment corresponding to residues 32–36 of thymopoietin. It is not a Khavinson cytomedine, Thymalin, thymulin or thymosin alpha-1. trial
- Research only: Not approved advice for self-experimentation; legality and access vary by place. forum
Stacks
- Multi-bioregulator stacks: Often combined by organ system in protocols. forum
- Less is clearer: Solo runs make personal n=1 easier to interpret than five-compound blasts. forum
Storage notes
- No mix instructions here: STUDresearch does not list reconstitution, diluent volumes, or syringe unit charts. People reconstitute many different ways and vial labels differ — that content creates more confusion than clarity. forum
- Storage (general talk only): Unopened research products are usually kept cool, dry, and away from light per the seller label. Anything after first use is product-specific — follow the label, not a universal forum SOP. forum
Watch for
- Generally mild claims: Vendor literature often claims good tolerability — independent long-term data limited. forum
- Allergy / unknown impurities: Gray-market risk. forum
- Injection site (if injected): Redness, itch, lumps, bruise — technique and product quality matter. forum
- Unknowns: Long-term safety for gray-market preparations is often poorly characterized. forum
- Stack noise: Sides logged on multi-agent stacks cannot be blamed cleanly on one compound. forum
- Seek care red flags: Severe allergic reaction, chest pain, neuro changes, or uncontrolled BP/glucose need real medical care — not forum advice. forum
Evidence mix
Mostly community / anecdote tags
Full: every bullet (trial + community). Use Scan for a faster bro-science read.